Business Description
Lipidor AB
ISIN : SE0012558617
Description
Lipidor AB is a pharmaceutical development company with a pipeline of drug development projects in the preclinical and clinical phases. The company develops drugs for the treatment of skin diseases such as psoriasis, bacterial skin infections, and atopic dermatitis.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 43.34 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.04 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.82 | |||||
| Beneish M-Score | -3.21 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -53.6 | |||||
| 3-Year EBITDA Growth Rate | 17.8 | |||||
| 3-Year EPS without NRI Growth Rate | 15.4 | |||||
| 3-Year FCF Growth Rate | 3.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.6 | |||||
| 9-Day RSI | 48.35 | |||||
| 14-Day RSI | 49.44 | |||||
| 6-1 Month Momentum % | -18.18 | |||||
| 12-1 Month Momentum % | -86.41 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.99 | |||||
| Quick Ratio | 2.99 | |||||
| Cash Ratio | 2.85 | |||||
| Days Sales Outstanding | 1099.2 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.7 | |||||
| Shareholder Yield % | -24.82 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -17393.1 | |||||
| Net Margin % | -15550.58 | |||||
| FCF Margin % | -11837.5 | |||||
| ROA % | -146.03 | |||||
| ROIC % | -196.83 | |||||
| ROC (Joel Greenblatt) % | -2054.74 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 0.01 | |||||
| PS Ratio | 188 | |||||
| PB Ratio | 8.95 | |||||
| EV-to-EBIT | -10.43 | |||||
| EV-to-Forward-EBIT | -7.69 | |||||
| EV-to-EBITDA | -10.87 | |||||
| EV-to-Forward-EBITDA | -7.73 | |||||
| EV-to-Revenue | 1503.18 | |||||
| EV-to-Forward-Revenue | 7.44 | |||||
| EV-to-FCF | -12.04 | |||||
| Earnings Yield (Greenblatt) % | -9.59 | |||||
| FCF Yield % | -7.04 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lipidor AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.008 | ||
| EPS (TTM) (€) | -0.017 | ||
| Beta | 4.03 | ||
| Volatility % | 1351.13 | ||
| 14-Day RSI | 49.44 | ||
| 14-Day ATR (€) | 0.00256 | ||
| 20-Day SMA (€) | 0.0046 | ||
| 12-1 Month Momentum % | -86.41 | ||
| 52-Week Range (€) | 0.0002 - 0.052668 | ||
| Shares Outstanding (Mil) | 813.4 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Lipidor AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Lipidor AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Lipidor AB Frequently Asked Questions
What is Lipidor AB(FRA:L7R)'s stock price today?
The current price of FRA:L7R is €0.00. The 52 week high of FRA:L7R is €0.05 and 52 week low is €0.00.
When is next earnings date of Lipidor AB(FRA:L7R)?
The next earnings date of Lipidor AB(FRA:L7R) is 2025-02-28.
Does Lipidor AB(FRA:L7R) pay dividends? If so, how much?
Lipidor AB(FRA:L7R) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers